Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003077399 | SCV003463119 | pathogenic | Hawkinsinuria; Tyrosinemia type III | 2023-11-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln205*) in the HPD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPD are known to be pathogenic (PMID: 10942115, 23036342). This variant is present in population databases (rs762267460, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with HPD-related conditions. ClinVar contains an entry for this variant (Variation ID: 2153024). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV003077399 | SCV005631938 | likely pathogenic | Hawkinsinuria; Tyrosinemia type III | 2024-03-13 | criteria provided, single submitter | clinical testing |